Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilin Tang

Showing results (91-100 of 344) with videos related to

Pageof 35
Sort By:
Journal of Clinical Pathology|June 12, 2012
Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myelomaDingsheng Liu, Pei Lin, Ying Hu, et al.
Leukemia Research|November 9, 2020
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangementHaipeng Shao, Wei Wang, Jinming Song, et al.
Experimental and Molecular Pathology|April 21, 2019
Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomesWei Xie, Sa A Wang, C Cameron Yin, et al.
Blood Neoplasia|March 30, 2026
Atypical single <i>PML</i>::<i>RARA</i> fusion in acute promyelocytic leukemia: mechanisms and clinical implicationsPing Yang, Guilin Tang, Yi Zhou, et al.
Leukemia & Lymphoma|January 13, 2025
Unusually indolent CML: a stable non-responder without complete cytogenetic remission for 30 years including 17 years on tyrosine kinase inhibitor therapyQiudan Shen, Guilin Tang, Fadi G Haddad, et al.
Experimental and Molecular Pathology|November 15, 2020
Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcomeWei Yin, Wei Liu, Ming Guo, et al.
Plos One|November 12, 2020
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapyJames Crespo, Hongxia Sun, Jimin Wu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 28, 2020
Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalitiesArash Ronaghy, Shimin Hu, Zhenya Tang, et al.
Cytometry. Part B, Clinical Cytometry|June 19, 2019
Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones)Zhining Chen, Chi Young Ok, Wei Wang, et al.
Cancer Medicine|June 8, 2019
Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?Zhining Chen, Yi Sun, Wei Xie, et al.
Pageof 35

Showing results (91-100 of 344) with videos related to

Sort By:
Pageof 35
Journal of Clinical Pathology|June 12, 2012
Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myelomaDingsheng Liu, Pei Lin, Ying Hu, et al.
Leukemia Research|November 9, 2020
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangementHaipeng Shao, Wei Wang, Jinming Song, et al.
Experimental and Molecular Pathology|April 21, 2019
Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomesWei Xie, Sa A Wang, C Cameron Yin, et al.
Blood Neoplasia|March 30, 2026
Atypical single <i>PML</i>::<i>RARA</i> fusion in acute promyelocytic leukemia: mechanisms and clinical implicationsPing Yang, Guilin Tang, Yi Zhou, et al.
Leukemia & Lymphoma|January 13, 2025
Unusually indolent CML: a stable non-responder without complete cytogenetic remission for 30 years including 17 years on tyrosine kinase inhibitor therapyQiudan Shen, Guilin Tang, Fadi G Haddad, et al.
Experimental and Molecular Pathology|November 15, 2020
Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcomeWei Yin, Wei Liu, Ming Guo, et al.
Plos One|November 12, 2020
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapyJames Crespo, Hongxia Sun, Jimin Wu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 28, 2020
Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalitiesArash Ronaghy, Shimin Hu, Zhenya Tang, et al.
Cytometry. Part B, Clinical Cytometry|June 19, 2019
Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones)Zhining Chen, Chi Young Ok, Wei Wang, et al.
Cancer Medicine|June 8, 2019
Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?Zhining Chen, Yi Sun, Wei Xie, et al.
Pageof 35